Disproquima SA - Strategy, SWOT and Corporate Finance Report
SummaryDisproquima SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Disproquima SA (Disproquima) is a marketer and distributor of wide range of functional ingredients. The company’s product portfolio includes active pharmaceutical ingredients, vitamins and minerals, antioxidants, compression agents, disgregation agents, solution stabilizers, skin bioactive sweeteners and cellulose derivatives. The company offers products for skin care, sun care, hair care and oral care, anti-ageing and rejuvenation, and skin barrier protection. It caters to the pharmaceutical, food, beauty and personal care and feed industries. Disproquima has business presence in Spain, Madrid, Portugal, Brazil, France, Germany, Italy, Mexico, India, Morocco, Algeria, Tunisia, and China. Disproquima is headquartered in Terrassa, Barcelona, Spain.
Scope
- Detailed information on Disproquima SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Disproquima SA in the form of a SWOT analysis
- An in-depth view of the business model of Disproquima SA including a breakdown and examination of key business segments
- Intelligence on Disproquima SA's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Disproquima SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons To Buy
- Gain understanding of Disproquima SA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Disproquima SA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Disproquima SA's business structure, strategy and prospects.
Aceto is engaged in the development, marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products. The company's three principal segments are: Human Health, which includes finished dosage form generic drugs and nutraceutical products; Pharmaceutical Ingredients, which consist of Active Pharmaceutical Ingredients and Pharmaceutical Intermediates; and Performance Chemicals, which includes specialty chemicals and agricultural protection products.
MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.
For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.
MarketLine’ holistic business intelligence report collection includes:
Industry Intelligence
‒ Industry Profiles
‒ Market Forecasts
‒ Porter’s Five Forces Analysis
Company Intelligence
‒ Company Profiles
‒ SWOT Analysis
‒ Financial Deals
Country and City Intelligence
‒ Country and City Profiles
‒ PEST/PESTLE Analysis
‒ Socio and macro-economic indicators
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.